Canadian Markets open in 7 hrs 22 mins

Johnson & Johnson (JNJ)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
123.47-0.27 (-0.22%)
At close: 4:02PM EDT
People also watch
PGMRKKOPFEXOM
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close123.74
Open123.85
Bid0.00 x
Ask0.00 x
Day's Range123.13 - 123.90
52 Week Range109.32 - 129.00
Volume4,381,766
Avg. Volume6,701,950
Market Cap334.71B
Beta0.67
PE Ratio (TTM)20.75
EPS (TTM)5.95
Earnings DateJul 18, 2017
Dividend & Yield3.20 (2.59%)
Ex-Dividend Date2017-02-24
1y Target Est128.82
Trade prices are not sourced from all markets
  • Amgen: The Bear Case From a Bull
    Motley Foolyesterday

    Amgen: The Bear Case From a Bull

    Amgen's top-selling anti-inflammatory drug, Enbrel, may have already hit its high-water mark.

  • The Wall Street Journal3 days ago

    [$$] Sanofi 1Q Net Profit Rises on Sale of Animal-Health Unit

    French drugmaker Sanofi said 1Q net profit jumped to about $6.2 billion, boosted by the sale of its animal-health business. To revive growth, Sanofi has boosted its research and is seeking to acquire an ...

  • Reuters3 days ago

    Global med-tech firms, India locked in tussle after stent price sting

    NEW DELHI/MUMBAI (Reuters) - A group of global medical-technology companies plans to tell Indian officials next month that any further price control measures would risk future investments and make them less likely to introduce new products in the country, according to an industry source familiar with the matter. The lobbying effort by Abbott Laboratories, Boston Scientific, Johnson & Johnson and others comes after the government of Prime Minister Narendra Modi in February set a price cap for stents - small wire-mesh structures used to treat blocked arteries - slashing prices that patients pay for some devices by about 75 percent.